- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Leriglitazone is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- A16AX23 Leriglitazone · Metabolic disease treatments, including enzyme replacement, subgroup A16A, subgroup A16AX
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- Yes
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Identifiers
- UNII K824X25AYACAS 146062-44-4DrugBank DB15021Q27156475
All presentations
No presentations of Leriglitazone are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Leriglitazone available for export from India?
No presentation of Leriglitazone is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Leriglitazone authorised in the European Union?
Yes. Leriglitazone has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Leriglitazone need cold chain shipping?
No listed presentation of Leriglitazone is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Leriglitazone in?
Leriglitazone is classified under ATC code A16AX23 (Leriglitazone).
References
- Nezglyal: European public assessment report (EPAR). European Medicines Agency. Retrieved 24 September 2026
Request Leriglitazone for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.